Bionik Laboratories Stock Price - BNKL

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Bionik Laboratories Corp. (QB) BNKL OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.045 0.045 0.045 0.045 0.045 09:30:01
Bid Price Ask Price Spread Spread % News
0.04 0.045 0.005 11.11% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 2,500 36.52k 0.03 - 0.18
Last Trade Time Type Quantity Stock Price Currency
15:05:10 2,500 $0.05 USD

Bionik Laboratories Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 15.77M 350.48M $ -29.53k - -534.13 21.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Bionik Laboratories Corp. (QB) News

Real-Time news about Bionik Laboratories Corp. (QB) (OTCBB): 0 recent articles

Latest BNKL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BNKL Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.070.070.0450.048310k32k16k-0.025-35.71%
1 Month0.04510.070.03980.045535066k17k-0.0001-0.22%
3 Months0.050.070.03750.04751001M44k-0.005-10.00%
6 Months0.0640.070.0320.0519101M45k-0.019-29.69%
1 Year0.13250.18250.0320.0817101M50k-0.0875-66.04%
3 Years1.251.480.0320.2503101M31k-1.205-96.40%
5 Years1.251.480.0320.2503101M31k-1.205-96.40%

Bionik Laboratories Corp. (QB) Description

Bionik Laboratories is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges through the continuum from hospital to home. Our focus is NeuroRecovery within Reach", which is the use of the Company's robots to assist patients to rewire a segment of their brains after injury, and is also known as neuroplasticity. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and and other mobility impaired individuals including three products in market and four products in various stages of development. The InMotion Systems - the InMotion Arm, InMotion Wrist, InMotion Hand are designed to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neurorecovery. The Company is also developing a home version of the InMotion technology, as well as a lower-body wearable assistive product based in the Company's existing ARKE lower body exoskeleton technology, which could allow certain mobility impaired individuals to walk better, which the Company intends to launch in the consumer marketplace.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20181023 04:54:14